Free Trial
NASDAQ:ADUS

Addus HomeCare (ADUS) Stock Price, News & Analysis

$110.66
0.00 (0.00%)
(As of 05/20/2024 ET)
Today's Range
$109.69
$111.04
50-Day Range
$91.70
$110.87
52-Week Range
$78.35
$111.99
Volume
60,845 shs
Average Volume
123,352 shs
Market Capitalization
$1.81 billion
P/E Ratio
27.46
Dividend Yield
N/A
Price Target
$108.57

Addus HomeCare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
1.9% Downside
$108.57 Price Target
Short Interest
Healthy
2.65% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.50
Upright™ Environmental Score
News Sentiment
0.68mentions of Addus HomeCare in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$33,385 Sold Last Quarter
Proj. Earnings Growth
10.45%
From $4.40 to $4.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.53 out of 5 stars

Medical Sector

94th out of 918 stocks

Home Health Care Services Industry

3rd out of 8 stocks

ADUS stock logo

About Addus HomeCare Stock (NASDAQ:ADUS)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

ADUS Stock Price History

ADUS Stock News Headlines

Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update
Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $119.00
Addus HomeCare: Q1 Earnings Snapshot
Addus HomeCare Corporation (ADUS)
ADUS- A Home Health Care Provider With Solid Growth
4 Analysts Assess Addus HomeCare: What You Need To Know
See More Headlines
Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/06/2024
Today
5/21/2024
Next Earnings (Estimated)
7/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Current Symbol
NASDAQ:ADUS
Employees
34,846
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$108.57
High Stock Price Target
$119.00
Low Stock Price Target
$83.00
Potential Upside/Downside
-1.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$62.52 million
Pretax Margin
7.94%

Debt

Sales & Book Value

Annual Sales
$1.06 billion
Cash Flow
$5.05 per share
Book Value
$43.58 per share

Miscellaneous

Free Float
15,617,000
Market Cap
$1.81 billion
Optionable
Optionable
Beta
0.96
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

ADUS Stock Analysis - Frequently Asked Questions

Should I buy or sell Addus HomeCare stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last year. There are currently 1 sell rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ADUS shares.
View ADUS analyst ratings
or view top-rated stocks.

What is Addus HomeCare's stock price target for 2024?

8 Wall Street analysts have issued 12 month price objectives for Addus HomeCare's stock. Their ADUS share price targets range from $83.00 to $119.00. On average, they anticipate the company's share price to reach $108.57 in the next year. This suggests that the stock has a possible downside of 1.9%.
View analysts price targets for ADUS
or view top-rated stocks among Wall Street analysts.

How have ADUS shares performed in 2024?

Addus HomeCare's stock was trading at $92.85 on January 1st, 2024. Since then, ADUS stock has increased by 19.2% and is now trading at $110.66.
View the best growth stocks for 2024 here
.

When is Addus HomeCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 29th 2024.
View our ADUS earnings forecast
.

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) posted its quarterly earnings data on Monday, May, 6th. The company reported $1.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.97 by $0.24. The business earned $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a net margin of 6.04% and a trailing twelve-month return on equity of 10.03%. The business's revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.84 EPS.

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.80%), Silvercrest Asset Management Group LLC (3.90%), WCM Investment Management LLC (3.00%), Principal Financial Group Inc. (2.17%), Price T Rowe Associates Inc. MD (1.93%) and Wasatch Advisors LP (1.89%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Michael D Wattenbarger, Monica Raines, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham.
View institutional ownership trends
.

How do I buy shares of Addus HomeCare?

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ADUS) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners